Mortality hazard and survival after tuberculosis treatment

Thaddeus L. Miller, Fernando Wilson, Jenny W. Pang, Suzanne Beavers, Sally Hoger, Sharon Sharnprapai, Melissa Pagaoa, Dolly J. Katz, Stephen E. Weis

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objectives: We compared mortality among tuberculosis (TB) survivors and a similar population. Methods: We used local health authority records from 3 USsites toidentify 3853 persons who completed adequate treatment of TB and 7282 individuals diagnosed with latent TB infection 1993 to 2002. We then retrospectively observed mortality after 6 to 16 years of observation. We ascertained vital status as of December 31, 2008, using the Centers for Disease Control and Prevention's National Death Index. We analyzed mortality rates, hazards, and associations using Cox regression. Results: We traced 11135 individuals over 119 772 person-years of observation. We found more all-cause deaths (20.7% vs 3.1%) among posttreatment TB patients than among the comparison group, an adjusted average excess of 7.6 deaths per 1000 person-years (8.8 vs 1.2; P<.001). Mortality among posttreatment TB patients varied with observable factors such as race, site of disease, HIV status, and birth country. Conclusions: Fully treated TB is still associated with substantial mortality risk. Cure as currently understood may be insufficient protection against TB-associated mortality in the years after treatment, and TB prevention may be a valuable opportunity to modify this risk.

Original languageEnglish (US)
Pages (from-to)930-937
Number of pages8
JournalAmerican journal of public health
Volume105
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Tuberculosis
Survival
Mortality
Therapeutics
Observation
Latent Tuberculosis
Centers for Disease Control and Prevention (U.S.)
Survivors
Cause of Death
HIV
Parturition
Health
Population

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Miller, T. L., Wilson, F., Pang, J. W., Beavers, S., Hoger, S., Sharnprapai, S., ... Weis, S. E. (2015). Mortality hazard and survival after tuberculosis treatment. American journal of public health, 105(5), 930-937. https://doi.org/10.2105/AJPH.2014.302431

Mortality hazard and survival after tuberculosis treatment. / Miller, Thaddeus L.; Wilson, Fernando; Pang, Jenny W.; Beavers, Suzanne; Hoger, Sally; Sharnprapai, Sharon; Pagaoa, Melissa; Katz, Dolly J.; Weis, Stephen E.

In: American journal of public health, Vol. 105, No. 5, 01.05.2015, p. 930-937.

Research output: Contribution to journalArticle

Miller, TL, Wilson, F, Pang, JW, Beavers, S, Hoger, S, Sharnprapai, S, Pagaoa, M, Katz, DJ & Weis, SE 2015, 'Mortality hazard and survival after tuberculosis treatment', American journal of public health, vol. 105, no. 5, pp. 930-937. https://doi.org/10.2105/AJPH.2014.302431
Miller, Thaddeus L. ; Wilson, Fernando ; Pang, Jenny W. ; Beavers, Suzanne ; Hoger, Sally ; Sharnprapai, Sharon ; Pagaoa, Melissa ; Katz, Dolly J. ; Weis, Stephen E. / Mortality hazard and survival after tuberculosis treatment. In: American journal of public health. 2015 ; Vol. 105, No. 5. pp. 930-937.
@article{af9686a1ed6b44fb878ed4425d2d3692,
title = "Mortality hazard and survival after tuberculosis treatment",
abstract = "Objectives: We compared mortality among tuberculosis (TB) survivors and a similar population. Methods: We used local health authority records from 3 USsites toidentify 3853 persons who completed adequate treatment of TB and 7282 individuals diagnosed with latent TB infection 1993 to 2002. We then retrospectively observed mortality after 6 to 16 years of observation. We ascertained vital status as of December 31, 2008, using the Centers for Disease Control and Prevention's National Death Index. We analyzed mortality rates, hazards, and associations using Cox regression. Results: We traced 11135 individuals over 119 772 person-years of observation. We found more all-cause deaths (20.7{\%} vs 3.1{\%}) among posttreatment TB patients than among the comparison group, an adjusted average excess of 7.6 deaths per 1000 person-years (8.8 vs 1.2; P<.001). Mortality among posttreatment TB patients varied with observable factors such as race, site of disease, HIV status, and birth country. Conclusions: Fully treated TB is still associated with substantial mortality risk. Cure as currently understood may be insufficient protection against TB-associated mortality in the years after treatment, and TB prevention may be a valuable opportunity to modify this risk.",
author = "Miller, {Thaddeus L.} and Fernando Wilson and Pang, {Jenny W.} and Suzanne Beavers and Sally Hoger and Sharon Sharnprapai and Melissa Pagaoa and Katz, {Dolly J.} and Weis, {Stephen E.}",
year = "2015",
month = "5",
day = "1",
doi = "10.2105/AJPH.2014.302431",
language = "English (US)",
volume = "105",
pages = "930--937",
journal = "American Journal of Public Health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
number = "5",

}

TY - JOUR

T1 - Mortality hazard and survival after tuberculosis treatment

AU - Miller, Thaddeus L.

AU - Wilson, Fernando

AU - Pang, Jenny W.

AU - Beavers, Suzanne

AU - Hoger, Sally

AU - Sharnprapai, Sharon

AU - Pagaoa, Melissa

AU - Katz, Dolly J.

AU - Weis, Stephen E.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Objectives: We compared mortality among tuberculosis (TB) survivors and a similar population. Methods: We used local health authority records from 3 USsites toidentify 3853 persons who completed adequate treatment of TB and 7282 individuals diagnosed with latent TB infection 1993 to 2002. We then retrospectively observed mortality after 6 to 16 years of observation. We ascertained vital status as of December 31, 2008, using the Centers for Disease Control and Prevention's National Death Index. We analyzed mortality rates, hazards, and associations using Cox regression. Results: We traced 11135 individuals over 119 772 person-years of observation. We found more all-cause deaths (20.7% vs 3.1%) among posttreatment TB patients than among the comparison group, an adjusted average excess of 7.6 deaths per 1000 person-years (8.8 vs 1.2; P<.001). Mortality among posttreatment TB patients varied with observable factors such as race, site of disease, HIV status, and birth country. Conclusions: Fully treated TB is still associated with substantial mortality risk. Cure as currently understood may be insufficient protection against TB-associated mortality in the years after treatment, and TB prevention may be a valuable opportunity to modify this risk.

AB - Objectives: We compared mortality among tuberculosis (TB) survivors and a similar population. Methods: We used local health authority records from 3 USsites toidentify 3853 persons who completed adequate treatment of TB and 7282 individuals diagnosed with latent TB infection 1993 to 2002. We then retrospectively observed mortality after 6 to 16 years of observation. We ascertained vital status as of December 31, 2008, using the Centers for Disease Control and Prevention's National Death Index. We analyzed mortality rates, hazards, and associations using Cox regression. Results: We traced 11135 individuals over 119 772 person-years of observation. We found more all-cause deaths (20.7% vs 3.1%) among posttreatment TB patients than among the comparison group, an adjusted average excess of 7.6 deaths per 1000 person-years (8.8 vs 1.2; P<.001). Mortality among posttreatment TB patients varied with observable factors such as race, site of disease, HIV status, and birth country. Conclusions: Fully treated TB is still associated with substantial mortality risk. Cure as currently understood may be insufficient protection against TB-associated mortality in the years after treatment, and TB prevention may be a valuable opportunity to modify this risk.

UR - http://www.scopus.com/inward/record.url?scp=84926642385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926642385&partnerID=8YFLogxK

U2 - 10.2105/AJPH.2014.302431

DO - 10.2105/AJPH.2014.302431

M3 - Article

VL - 105

SP - 930

EP - 937

JO - American Journal of Public Health

JF - American Journal of Public Health

SN - 0090-0036

IS - 5

ER -